News

Law

Asset Management

Investment Banking

Wealth

Hedge Funds

People

Newsletters

Events

Lists

News

UK under 30s to be offered alternative to AstraZeneca vaccine over blood clot risks

Four people in a million risk blood clots after getting the jab

People under the age of 30 should be offered the Pfizer or Moderna vaccine instead of the AstraZeneca jab where possible, the UK's Joint Committee on Vaccination and Immunisation said, in a “change of course” for the country's roll out.

Pharmaceutical firm AstraZeneca has had a turbulent few weeks as several countries expressed concerns over the safety of its vaccine, as cases of blood clots were reported among younger people, and some suspended the administration of the shot, including Germany, Spain Italy and France.

WSJ Logo